Elevated fractalkine in patients with obstructive sleep apnea hypopnea syndrome

Sleep and Breathing

Volumn 17, Issue 1, 2013, Pages 203-208

  Yang, Yu ^a   Wang, Yina ^a   Li, Yayong ^b   Chen, Ping ^a   Luo, Yingquan ^a   Yang, Yue ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Artherosclerosis; Continuous positive airway pressure; Fractalkine; Obstructive sleep apnea hypopnea syndrome

Indexed keywords

FRACTALKINE;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; OXYGEN SATURATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP DISORDERED BREATHING;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHEMOKINE CX3CL1; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84874189562     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-012-0674-6     Document Type: Article

References (36)

1. Fava C, Montagnana M, Favaloro EJ, Guidi GC, Lippi G (2011) Obstructive sleep apnea syndrome and cardiovascular diseases. Semin Thromb Hemost 37:280-297
2. Drager LF, Polotsky VY, Lorenzi-Filho G (2011) Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 140:534-542
3. Quercioli A, Mach F, Montecucco F (2010) Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep Breath 14:261-269
4. Williams A, Scharf SM (2007) Obstructive sleep apnea, cardiovascular disease, and inflammation - is NF-kappa B the key? Sleep Breath 11:69-76
5. Bazan JF, Bacon KB, Hardiman GJ (1997) A new class of membrane bound chemokine with a CX3C motif. Nature 385:640-644
6. Liu H, Jiang D (2011) Fractalkine/CX3CR1 and atherosclerosis. Clinica Chimica Acta 412:1180-1186
7. Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE (2001) Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol 159:1521-1530
8. Efsen E, Grappone C, DeFranco RM, Milani S, Romanelli RG, Bonacchi A, Caligiuri A, Failli P, Annunziato F, Pagliai G, Pinzani M, Laffi G, Gentilini P, Marra F (2002) Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. J Hepatol 37:39-47
9. Robinson LA, Nataraj C, Thomas DW, Howell DN, Griffiths R, Bautch V, Patel DD, Feng L, Coffman TM (2000) A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 165:6067-6072
10. Mills PJ, Dimsdale JE (2004) Sleep apnea: a model for studying cytokines, sleep and sleep disruption. Brain Behav Immun 18:298-303
11. Chen XJ, Cheng DY, Yang L, Xia XQ, Guan J (2006) Effect of breviscapine on fractalkine expression in chronic hypoxica rats. Chin Med J 119:1465-1468
12. American Academy of Sleep Medicine Task Force (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667-689
13. Kerfoot SM, Lord SE, Bell RB, Gill V, Robbins SM, Kubes P (2003) Human fractalkine mediates leukocyte adhesion but not capture under physiological shear conditions: a mechanism for selective monocyte recruitment. Eur J Immunol 33:729-739
14. Umehara H, Goda S, Imai T, Nagano Y, Minami Y, Tanaka Y, Okazaki T, Bloom ET, Domae N (2001) Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. Immunol Cell Biol 79:298-302
15. Vitale S, Schmid-Alliana A, Breuil V, Pomeranz M, Millet MA, Rossi B, Schmid-Antomarchi H (2004) Soluble fractalkine prevents monocyte chemoattractant protein-1-induced monocyte migration via inhibition of stressactivated protein kinase 2/p38 and matrix metalloproteinase activities. J Immunol 172:585-592
16. Cambien B, Pomeranz M, Schmid-Antomarchi H, Millet MA, Breittmayer V, Rossi B, Schmid-Alliana A (2001) Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 97:2031-2037
17. Volin MV, Huynh N, Klosowska K, Reyes RD, Woods JM (2010) Fractalkine-induced endothelial cell migration requires MAP kinase signaling. Pathobiology 77:7-16
18. Geissmann F, Jung S, Littmann DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82
19. Barlic J, Zhang Y, Foley JF, Murphy PM (2006) Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor {gamma}-dependent pathway. Circulation 114:807-819
20. Yang XP, Jones RA, Rivers JH, Chen G, Cai Z, Fox-Talbot K, Irani K, Becker LC (2007) Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak-Stat5 pathway. Circ Res 101:1001-1008
21. Chandrasekar B, Mummidi S, Perla RP, Bysani S, Dulin NO, Liu F, Melby PC (2003) Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem J 373:547-558
22. Kansra V, Groves C, Gutierrez Ramos JC, Polakiewicz RD (2001) Phosphatidylinositol 3-kinase- dependent extracellular calcium influx is essential for CX(3)CR1-mediated activation of the mitogen-activated protein kinase cascade. J Biol Chem 276:31831-31838
23. Yoneda O, Imai T, Goda S, Inoue H, Yamauchi A, Okazaki T (2000) Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 164:4055-4062
24. Foussat A, Coulomb-L'Hermine A, Gosling J, Krzysiek R, Durand-Gasselin I, Schall T, Balian A, Richard Y, Galanaud P, Emilie D (2000) Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 30:87-97
25. Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, Kakizaki M, Dohmae N, Yoshie O, Imai T (2002) Dual functions of fractalkine/CX3CR1 in trafficking of circulating cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 138:6173-6180
26. White GE, Tan TC, John AE, Whatling C, McPheat WL, Greaves DR (2010) Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling. Cardiovasc Res 85:825-835
27. Schäfer A, Schulz C, Eigenthaler M, Fraccarollo D, Kobsar A, Gawaz M, Ertl G, Walter U, Bauersachs J (2004) Novel role of the membrane bound chemokine fractalkine in platelet activation and adhesion. Blood 103:407-412
28. Schulz C, Schäfer A, Stolla M, Kerstan S, Lorenz M, von Brühl ML, Schiemann M, Bauersachs J, Gloe T, Busch DH, Gawaz M, Massberg S (2007) Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation 116:764-773
29. McDermott DH, Fong AM, Yang Q, Sechler JM, Cupples LA, Merrell MN, Wilson PW, D'Agostino RB, O'Donnell CJ, Patel DD, Murphy PM (2003) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 111:1241-1246
30. Moatti D, Faure S, Fumeron F, Mel-W A, Seknadji P, McDermott DH, Debré P, Aumont MC, Murphy PM, de Prost D, Combadière C (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925-1928
31. Shah R, Hinkle CC, Ferguson JF, Mehta NN, Li M, Qu L, Lu Y, Putt ME, Ahima RS, Reilly MP (2011) Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes 60:1512-1518
32. Vgontzas AN, Bixler EO, Chrousos GP (2005) Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9:211-224
33. Tam CS, Wong M, McBain R, Bailey S, Waters KA (2006) Inflammatory measures in children with obstructive sleep apnoea. J Paediatr Child Health 42:277-282
34. Ludwig A, Berkhout T, Moores K, Groot P, Chapman G (2002) Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity. J Immunol 168:604-612
35. Garcia GE, Xia Y, Chen S, Wang Y, Ye RD, Harrison JK, Bacon KB, Zerwes HG, Feng L (2000) NF-κB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1β, TNF-α, and LPS. J Leukoc Biol 67:577-584
36. Lin CM, Davidson TM, Ancoli-Israel S (2008) Gender differences in obstructive sleep apnea and treatment implications. Sleep Med Rev 12:481-496